1Kaeberlein M,McVey M,Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiaeby two different mechanisms[J].Genes and Development,1999,(19):2570-2580.
2Donmez G,Outeiro T F. SIRT1 and SIRT2:emerging targets in neurodegeneration[J].EMBO Mol Med,2013,(03):344-352.
3Michan S,Sinclair D. Sirtuins in mammals:insights into their biological function[J].Biochemical Journal,2007,(01):1-13.
4Klein W L. Ab toxicity in Alzheimer's disease:globular oligomers (ADDLs) as new vaccine and drug targets[J].Neurochemistry International,2002,(05):345-352.
5Lesne S,Koh M T,Kotilinek L. A specific amyloid-beta protein assembly in the brain impairs memory[J].Nature,2006,(7082):352-357.
6Hardy J,Selkoe D J. The amyloid hypothesis of Alzheimer's disease:progress and problems on the road to therapeutics[J].Science,2002.353-356.
7Berg L,McKeel D W Jr,Miller J P. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease:relation of histologic markers to dementia severity,age,sex,and apolipoprotein E genotype[J].Archives of Neurology,1998.326-335.
8Julien C,Tremblay C,Emond V. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease[J].Journal of Neuropathology and Experimental Neurology,2009.48-58.
9Min S W,Cho S H,Zhou Y. Acetylation of tau inhibits its degradation and contributes to tauopathy[J].Neuron,2010.953-966.
10Albani D,Polito L,Batelli S. The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide[J].Journal of Neurochemistry,2009,(5):1445-1456.doi:10.1111/j.1471-4159.2009.06228.x.
